These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38461048)

  • 21. Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.
    Ozdil M; Sonmez C; Tugberk Bakar M; Alici Davutoglu E; Madazli R; Kilic S; Vural M; Perk Y
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():212-216. PubMed ID: 34534737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.
    Abu-Raya B; Maertens K; Munoz FM; Zimmermann P; Curtis N; Halperin SA; Rots N; Barug D; Holder B; Rice TF; Kampmann B; Leuridan E; Sadarangani M
    Vaccine; 2021 Oct; 39(44):6545-6552. PubMed ID: 34598822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.
    Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P
    JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy.
    Healy CM; Rench MA; Swaim LS; Timmins A; Vyas A; Sangi-Haghpeykar H; Ng N; Rajam G; ; Havers F; Schiffer J; Baker CJ
    Vaccine; 2020 Aug; 38(37):5955-5961. PubMed ID: 32709433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal tetanus-diphtheria-acellular pertussis vaccine effectiveness at preventing infant pertussis.
    Vargas-Zambrano JC; Clark LR; Johnson DR; Monfredo C; Pool V; Li L; Bouvet PE; Blangero Y; Macina D
    Vaccine; 2023 May; 41(18):2968-2975. PubMed ID: 37032227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of a liquid hexavalent DTaP-IPV-HB-PRP∼T vaccine after primary and booster vaccination of term and preterm infants born to women vaccinated with Tdap during pregnancy.
    Maertens K; Orije MRP; Huoi C; Boisnard F; Lyabis O
    Vaccine; 2023 Jan; 41(3):795-804. PubMed ID: 36528443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
    Havers FP; Skoff TH; Rench MA; Epperson M; Rajam G; Schiffer J; Hariri S; Swaim LS; Baker CJ; Healy CM
    Clin Infect Dis; 2023 Feb; 76(3):e1087-e1093. PubMed ID: 35642525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
    Thierry-Carstensen B; Jordan K; Uhlving HH; Dalby T; Sørensen C; Jensen AM; Heilmann C
    Vaccine; 2012 Aug; 30(37):5464-71. PubMed ID: 22776216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.
    Carlsson RM; Gustafsson L; Hallander HO; Ljungman M; Olin P; Gothefors L; Nilsson L; Netterlid E
    Vaccine; 2015 Jul; 33(31):3717-25. PubMed ID: 26057135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Brandon D; Kimmel M; Kuriyakose SO; Kostanyan L; Mesaros N
    Vaccine; 2018 Oct; 36(42):6325-6333. PubMed ID: 30197282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial.
    Perrett KP; Halperin SA; Nolan T; Carmona Martínez A; Martinón-Torres F; García-Sicilia J; Virta M; Vanderkooi OG; Zuccotti GV; Manzoni P; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Stranak Z; Merino Arribas JM; Cilleruelo Ortega MJ; Miranda-Valdivieso M; Arias Novas B; Ramos Amador JT; Omeñaca F; Baca M; Marchisio PG; Mesaros N
    Vaccine; 2020 Feb; 38(8):2105-2114. PubMed ID: 31776027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
    Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants.
    Knuutila A; Barkoff AM; Ivaska L; Tenhu E; Teräsjärvi J; van Gageldonk P; Buisman A; Mertsola J; He Q;
    Emerg Microbes Infect; 2023 Dec; 12(1):2204146. PubMed ID: 37060181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Pertussis Antibodies in Maternal Blood, Cord Serum, and Infants From Mothers With and Those Without Tdap Booster Vaccination During Pregnancy in Argentina.
    Fallo AA; Neyro SE; Manonelles GV; Lara C; Hozbor D; Zintgraff J; Mazzeo S; Davison HE; González S; Zapulla E; Canle O; Huespe M; Galas M; López EL
    J Pediatric Infect Dis Soc; 2018 Feb; 7(1):11-17. PubMed ID: 28040688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of pertussis, tetanus, and diphtheria antibodies in sera and breast milk from Tdap vaccinated women using a qualified multiplex assay.
    Portillo S; Oshinsky J; Williams M; Yoder S; Liang Y; Campbell JD; Laufer MK; Neuzil KM; Edwards KM; Pasetti MF
    mSphere; 2024 Apr; 9(4):e0052723. PubMed ID: 38497618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses.
    Orije MRP; García-Fogeda I; Van Dyck W; Corbière V; Mascart F; Mahieu L; Hens N; Van Damme P; Cools N; Ogunjimi B; Maertens K; Leuridan E
    Clin Infect Dis; 2022 Aug; 75(3):442-452. PubMed ID: 34849638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.